Mason, Barbara J.

Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence: The COMBINE Study: A Randomized Controlled Trial

Anton, R. F., O’Malley, S. S., Ciraulo, D. A., Cisler, R. A., Couper, D., Donovan, D. M., Gastfriend, D. R., Hosking, J. D., Johnson, B. A., LoCastro, J. S., et al. (2006) · JAMA

Substance Abuse Treatment and OutcomesAlcohol Consumption and Health Effects

Cited by 1,930

An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions

Crean, R. D., Crane, N. A., & Mason, B. J. (2011) · Journal of Addiction Medicine

Cannabis and Cannabinoid ResearchSubstance Abuse Treatment and Outcomes

Cited by 732

Gabapentin Treatment for Alcohol Dependence: A Randomized Clinical Trial

Mason, B. J., Quello, S., Goodell, V., Shadan, F., Kyle, M., & Begovic, A. (2014) · JAMA Internal Medicine

Substance Abuse Treatment and OutcomesAlcohol Consumption and Health Effects

Cited by 340

Identifying barriers to mental health help-seeking among young adults in the UK: a cross-sectional survey

Salaheddin, K., & Mason, B. (2016) · British Journal of General Practice

Mental Health Treatment and AccessPsychology and Mental Health

Cited by 329

A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence

Mason, B. J., Salvato, F. R., Williams, L. D., Ritvo, E. C., & Cutler, R. B. (1999) · Archives of General Psychiatry

Substance Abuse Treatment and OutcomesAlcohol Consumption and Health Effects

Cited by 271

A proof-of-concept randomized controlled study of gabapentin: effects on cannabis use, withdrawal and executive function deficits in cannabis-dependent adults.

Mason, B. J., Crean, R., Goodell, V., Light, J. M., Quello, S., Shadan, F., Buffkins, K., Kyle, M., Adusumalli, M., Begovic, A., et al. (2012) · Neuropsychopharmacology

Cannabis and Cannabinoid ResearchSubstance Abuse Treatment and Outcomes

Cited by 242

Glucocorticoid receptor antagonism decreases alcohol seeking in alcohol-dependent individuals

Vendruscolo, L. F., Estey, D., Goodell, V., Macshane, L. G., Logrip, M. L., Schlosburg, J. E., McGinn, M. A., Zamora-Martinez, E. R., Belanoff, J. K., Hunt, H. J., et al. (2015) · Journal of Clinical Investigation

Substance Abuse Treatment and OutcomesNeurotransmitter Receptor Influence on Behavior

Cited by 218

Development of pharmacotherapies for drug addiction: a Rosetta stone approach

Koob, G. F., Kenneth Lloyd, G., & Mason, B. J. (2009) · Nature Reviews Drug Discovery

Neurotransmitter Receptor Influence on BehaviorSubstance Abuse Treatment and Outcomes

Cited by 154

Existing and future drugs for the treatment of the dark side of addiction

Koob, G. F., & Mason, B. J. (2016) · Annual Review of Pharmacology and Toxicology

Neurotransmitter Receptor Influence on BehaviorSubstance Abuse Treatment and Outcomes

Cited by 121

Craving in response to stress induction in a human laboratory paradigm predicts treatment outcome in alcohol-dependent individuals

Higley, A. E., Crane, N. A., Spadoni, A. D., Quello, S. B., Goodell, V., & Mason, B. J. (2011) · Psychopharmacology

Substance Abuse Treatment and OutcomesNeurotransmitter Receptor Influence on Behavior

Cited by 116

Proof-of-concept human laboratory study for protracted abstinence in alcohol dependence: effects of gabapentin

Mason, B. J., Light, J. M., Williams, L. D., & Drobes, D. J. (2009) · Addiction Biology

Substance Abuse Treatment and OutcomesNeurotransmitter Receptor Influence on Behavior

Cited by 115

Gabapentin for the treatment of alcohol use disorder

Mason, B. J., Quello, S., & Shadan, F. (2018) · Expert Opinion on Investigational Drugs

Substance Abuse Treatment and OutcomesAlcohol Consumption and Health Effects

Cited by 104

Gabapentin enacarbil extended-release for alcohol use disorder: a randomized, double-blind, placebo-controlled, multisite trial assessing efficacy and safety

Falk, D. E., Ryan, M. L., Fertig, J. B., Devine, E. G., Cruz, R., Brown, E. S., Burns, H., Salloum, I. M., Newport, D. J., Mendelson, J., et al. (2019) · Alcoholism: Clinical and Experimental Research

Substance Abuse Treatment and OutcomesAlcohol Consumption and Health Effects

Cited by 89

Acamprosate and naltrexone treatment for alcohol dependence: an evidence-based risk-benefits assessment

Mason, B. J. (2003) · European Neuropsychopharmacology

Substance Abuse Treatment and OutcomesAlcohol Consumption and Health Effects

Cited by 75

Preclinical and clinical evidence for suppression of alcohol intake by apremilast

Grigsby, K. B., Mangieri, R. A., Roberts, A. J., Lopez, M. F., Firsick, E. J., Townsley, K. G., Beneze, A., Bess, J., Eisenstein, T. K., Meissler, J. J., et al. (2023) · Journal of Clinical Investigation

Substance Abuse Treatment and OutcomesNeurotransmitter Receptor Influence on Behavior

Cited by 64

Sleep disturbance in alcoholism: proposal of a simple measurement, and results from a 24-week randomized controlled study of alcohol-dependent patients assessing acamprosate efficacy

Perney, P., Lehert, P., & Mason, B. J. (2012) · Alcohol and Alcoholism

Substance Abuse Treatment and OutcomesSleep and related disorders

Cited by 48

Glucocorticoid receptor modulators decrease alcohol self-administration in male rats

McGinn, M. A., Tunstall, B. J., Schlosburg, J. E., Gregory-Flores, A., George, O., de Guglielmo, G., Mason, B. J., Hunt, H. J., Koob, G. F., & Vendruscolo, L. F. (2021) · Neuropharmacology

Neurotransmitter Receptor Influence on BehaviorSubstance Abuse Treatment and Outcomes

Cited by 35

Alcohol dependence and withdrawal increase sensitivity of central amygdalar GABAergic synapses to the glucocorticoid receptor antagonist mifepristone in male rats

Khom, S., Rodriguez, L., Gandhi, P., Kirson, D., Bajo, M., Oleata, C. S., Vendruscolo, L. F., Mason, B. J., & Roberto, M. (2022) · Neurobiology of Disease

Neuroscience and Neuropharmacology ResearchNeurotransmitter Receptor Influence on Behavior

Cited by 23